Syapse is a real-world evidence company dedicated to extinguishing the fear and burden of serious disease by advancing real-world care
To achieve more precise care for every patient, we need to transform real-world evidence into insights that can directly impact care. At Syapse, that is real-world care. It’s found in the way we empower healthcare organizations to work together in active, transparent partnerships, delivering complete patient insights to answer the questions that matter and then purposefully applying it at where patients receive care – driving real impact for cancer patients and beyond.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 27, 2022 | Series Unknown | $35M | 1 | — | — | Detail |
May 28, 2020 | Series F | $30M | 1 | — | — | Detail |
Nov 14, 2017 | Series D | $30M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Revelation Alpine | — | Series Unknown |
Roche Finance | — | Series F |
Intermountain Healthcare Innovation Fund | — | Series D |